Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2023 Filed Feb 25, 2023 00:50 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 25,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012957 · doc4.xml · derivative · entry 15 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,916 Underlying: Common Shares · 25,916 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F15 · shares: The issuer granted the 2023 restricted share units ("2023 RSUs") to the Reporting Person pursuant to the Issuer's 2022 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2022 net bonus to purchase Investment Shares and received a matching grant of 2023 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $67.75 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2023 RSUs that have not yet vested. F16 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F16 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 00:50 UTC |
Kobza JoshuaCOO
|
GrantCommon Shares | 6,910 | $67.75 | $468,152.50 |
DisclosureSEC source: 0001209191-23-012957 · doc4.xml · nonDerivative · entry 1 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,231.2575 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2022 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2022 net bonus to purchase common shares at a purchase price of $67.75 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 15 below pursuant to the Issuer's 2022 Bonus Swap Program is calculated based on, the last sale price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 21, 2023. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 00:59 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 73,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012975 · doc4.xml · derivative · entry 14 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,800 Underlying: Common Shares · 73,800 shares Expires 2026-02-22 F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 00:59 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 15,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012975 · doc4.xml · derivative · entry 13 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,686 Underlying: Common Shares · 15,686 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F12 · shares: The Issuer granted the 2023 restricted share units ("2023 RSUs") to the Reporting Person pursuant to the Issuer's 2022 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2022 net bonus to purchase Investment Shares and received a matching grant of 2023 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $67.75 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2023 RSUs that have not yet vested. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 00:59 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantCommon Shares | 4,112 | $67.84 | $278,958.08 |
DisclosureSEC source: 0001209191-23-012975 · doc4.xml · nonDerivative · entry 1 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,304.5726 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2022 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2022 net bonus to purchase common shares at a purchase price of CAD $91.69 per share. The purchase price was converted into its U.S. dollar equivalent using the Bank of Canada daily exchange rate on February 21. 2023. F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is calculated based on, the last sales price of a common share of the Issuer on the Toronto Stock Exchange on the trading day immediately preceding the grant date, in this case February 21, 2023. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 00:58 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 21,769 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012971 · doc4.xml · derivative · entry 14 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,769 Underlying: Common Shares · 21,769 shares Expires 2026-02-22 F15 · derivative.exercise_price: The shares reported represent an award of performance base restricted share units (the "2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning on January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 00:58 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 8,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012971 · doc4.xml · derivative · entry 13 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,889 Underlying: Common Shares · 8,889 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F13 · shares: The Issuer granted the 2023 restricted share units (2023 RSUs") to the Reporting Person pursuant to the Issuer's 2022 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2022 net bonus to purchase Investment Shares and received a matching grant of 2023 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $67.84 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2023 RSUs that have not yet vested. F14 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F14 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 00:58 UTC |
Fulton DuncanChief Corporate Officer
|
GrantCommon Shares | 1,975 | $67.84 | $133,984.00 |
DisclosureSEC source: 0001209191-23-012971 · doc4.xml · nonDerivative · entry 1 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,272.5759 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2022 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2022 net bonus to purchase common shares at a purchase price of CAD $91.69 per share. The purchase price was converted into its U.S. dollar equivalent using the Bank of Canada daily exchange rate on February 21, 2023. F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 13 below pursuant to the Issuer's 2022 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the Toronto Stock Exchange on the trading day immediately preceding the grant date, in this case February 21, 2023. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 00:57 UTC | GrantPerformance Share Unit · Derivative | 36,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012970 · doc4.xml · derivative · entry 17 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,900 Underlying: Common Shares · 36,900 shares Expires 2026-02-22 F16 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
|
| February 22, 2023 Filed Feb 25, 2023 00:57 UTC | GrantRestricted Share Units · Derivative | 14,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012970 · doc4.xml · derivative · entry 16 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,541 Underlying: Common Shares · 14,541 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F14 · shares: The Issuer granted the 2023 restricted share units ("2023 RSUs") to the Reporting Person pursuant to the Issuer's 2022 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2022 net bonus to purchase Investment Shares and received a matching grant of 2023 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $67.75 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2023 RSUs that have not yet vested. F15 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F15 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
|
| February 22, 2023 Filed Feb 25, 2023 00:57 UTC | GrantCommon Shares | 3,877 | $67.75 | $262,666.75 |
DisclosureSEC source: 0001209191-23-012970 · doc4.xml · nonDerivative · entry 1 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,390.9247 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2022 Bonus Swap Program under its 2014 Omnibus Incentive Plan. The Reporting Person elected to use 50% of his 2022 net bonus to purchase common shares at a purchase price of $67.75 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Omnibus Incentive Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 14 below pursuant to the Issuer's 2022 Bonus Swap Program is the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 21, 2023. Read SEC document |
|
| February 22, 2023 Filed Feb 25, 2023 00:53 UTC |
Siddiqui Sami A.Brand Pres., Popeyes, Americas
|
GrantPerformance Share Units · Derivative | 36,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012961 · doc4.xml · derivative · entry 16 Siddiqui Sami A. · CIK 0001829353 · Brand Pres., Popeyes, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,900 Underlying: Common Shares · 36,900 shares Expires 2026-02-22 F19 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 00:53 UTC |
Siddiqui Sami A.Brand Pres., Popeyes, Americas
|
GrantRestricted Share Units · Derivative | 8,902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012961 · doc4.xml · derivative · entry 15 Siddiqui Sami A. · CIK 0001829353 · Brand Pres., Popeyes, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,902 Underlying: Common Shares · 8,902 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F17 · shares: The Issuer granted the 2023 restricted share units ("2023 RSUS") to the Reporting Person pursuant to the Issuer's 2022 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2022 net bonus to purchase Investment Shares and received a matching grant of 2023 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $67.75 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2023 RSUs that have not yet vested. F18 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F18 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 00:53 UTC |
Siddiqui Sami A.Brand Pres., Popeyes, Americas
|
GrantCommon Shares | 2,373 | $67.75 | $160,770.75 |
DisclosureSEC source: 0001209191-23-012961 · doc4.xml · nonDerivative · entry 1 Siddiqui Sami A. · CIK 0001829353 · Brand Pres., Popeyes, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,643.8364 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2022 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2022 net bonus to purchase common shares at a purchase price of $67.75 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 17 below pursuant to the Issuer's 2022 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 21, 2023. F3 · balance_after: Reflects the transfer of 5,774 shares previously held directly by the Reporting Person to a revocable trust in a transaction exempt from reporting pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:34 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 212.7607 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002466 · doc4.xml · derivative · entry 15 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625.8385 Underlying: Common Shares · 212.7607 shares Expires 2025-02-25 F14 · derivative.exercise_price: The shares reported represents an award of performance based restricted share units (the "2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:34 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 76.773 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002466 · doc4.xml · derivative · entry 14 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,246.8859 Underlying: Common Shares · 76.773 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:34 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 19.4465 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002466 · doc4.xml · derivative · entry 13 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,342.2276 Underlying: Common Shares · 19.4465 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:34 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 111.4543 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002466 · doc4.xml · derivative · entry 12 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,424.0466 Underlying: Common Shares · 111.4543 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:34 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 185.9532 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002466 · doc4.xml · derivative · entry 11 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,397.0301 Underlying: Common Shares · 185.9532 shares Expires 2025-02-21 F11 · derivative.exercise_price: The shares reported represents an award of performance based restricted share units (the "2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:34 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 22.8351 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002466 · doc4.xml · derivative · entry 10 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750.3553 Underlying: Common Shares · 22.8351 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:34 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 287.2878 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002466 · doc4.xml · derivative · entry 8 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,602.2218 Underlying: Common Shares · 287.2878 shares Expires 2024-02-22 F8 · derivative.exercise_price: The shares reported represent an award of performance base restricted share units (the "2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:34 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 28.882 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002466 · doc4.xml · derivative · entry 7 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,478.6767 Underlying: Common Shares · 28.882 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F7 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:34 UTC |
Housman JeffreySee Remarks
|
SaleCommon Shares | 5,400.2643 | $65.04 | $351,233.19 |
DisclosureSEC source: 0001209191-23-002466 · doc4.xml · nonDerivative · entry 2 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,093.0287 F2 · shares: Represents shares sold to cover withholding tax obligations on the settlement of the previously reported vesting of the Reporting Person's restricted share units. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:34 UTC |
Housman JeffreySee Remarks
|
GrantCommon Shares | 112.2764 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002466 · doc4.xml · nonDerivative · entry 1 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,493.293 F1 · shares: Represents shares settled from dividend equivalent rights that accrued on a vested restricted share unit award in respect of dividends that were paid after the vesting of the award with a record date prior to the vesting of the award. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 18:37 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 510.6324 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002470 · doc4.xml · derivative · entry 16 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,502.8354 Underlying: Common Shares · 510.6324 shares Expires 2025-02-25 F17 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 18:37 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 122.7713 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002470 · doc4.xml · derivative · entry 15 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,787.1265 Underlying: Common Shares · 122.7713 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F16 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F16 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 18:37 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 298.6974 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002470 · doc4.xml · derivative · entry 14 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,976.4449 Underlying: Common Shares · 298.6974 shares Expires 2024-02-19 F15 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 18:37 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 47.7024 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002470 · doc4.xml · derivative · entry 13 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,745.4919 Underlying: Common Shares · 47.7024 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F14 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F14 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 18:37 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 49.0399 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002470 · doc4.xml · derivative · entry 12 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,906.5805 Underlying: Common Shares · 49.0399 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 18:37 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 179.8882 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002470 · doc4.xml · derivative · entry 11 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,666.5333 Underlying: Common Shares · 179.8882 shares Expires 2025-02-21 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2020-2 PBRSUs") granted to the Reporting Person. The 2020-2 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 18:37 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 232.4415 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002470 · doc4.xml · derivative · entry 10 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,996.2876 Underlying: Common Shares · 232.4415 shares Expires 2025-02-21 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2020-1 PBRSUs") granted to the Reporting Person. The 2020-1 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 18:37 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 56.0835 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002470 · doc4.xml · derivative · entry 9 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,754.9443 Underlying: Common Shares · 56.0835 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 18:37 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 478.813 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002470 · doc4.xml · derivative · entry 7 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,670.3697 Underlying: Common Shares · 478.813 shares Expires 2024-02-22 F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 18:37 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 81.0439 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002470 · doc4.xml · derivative · entry 6 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,761.2868 Underlying: Common Shares · 81.0439 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F7 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 18:37 UTC |
Shear David ChanPresident, International
|
SaleCommon Shares | 10,882.5625 | $65.04 | $707,801.87 |
DisclosureSEC source: 0001209191-23-002470 · doc4.xml · nonDerivative · entry 2 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,392.4332 F2 · shares: Represents shares sold to cover withholding tax obligations on the settlement of the previously reported vesting of the Reporting Person's restricted share units. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 18:37 UTC |
Shear David ChanPresident, International
|
GrantCommon Shares | 191.0219 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002470 · doc4.xml · nonDerivative · entry 1 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,274.9957 F1 · shares: Represents shares settled from dividend equivalent rights that accrued on a vested restricted share unit award in respect of dividends that were paid after the vesting of the award with a record date prior to the vesting of the award. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:26 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 340.4188 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002455 · doc4.xml · derivative · entry 8 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,001.5473 Underlying: Common Shares · 340.4188 shares Expires 2025-02-25 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:26 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 59.1185 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002455 · doc4.xml · derivative · entry 7 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,120.4967 Underlying: Common Shares · 59.1185 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:26 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 130.4721 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002455 · doc4.xml · derivative · entry 6 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,714.6383 Underlying: Common Shares · 130.4721 shares Expires 2024-12-15 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021-2 PBRSUs") granted to the Reporting Person. The 2021-2 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on December 15, 2024, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:26 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 86.9814 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002455 · doc4.xml · derivative · entry 5 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,476.4255 Underlying: Common Shares · 86.9814 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2022, December 15, 2023 and December 15, 2024. F8 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2022, December 15, 2023 and December 15, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:26 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 131.5883 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002455 · doc4.xml · derivative · entry 4 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,849.0815 Underlying: Common Shares · 131.5883 shares Expires 2024-09-01 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021-1 PBRSUs") granted to the Reporting Person. The 2021-1 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on September 1, 2024, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:26 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 66.3356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002455 · doc4.xml · derivative · entry 3 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,989.7583 Underlying: Common Shares · 66.3356 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F5 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:26 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
SaleCommon Shares | 2,293.6712 | $65.04 | $149,180.37 |
DisclosureSEC source: 0001209191-23-002455 · doc4.xml · nonDerivative · entry 2 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,345.3657 F2 · shares: Represents shares sold to cover withholding tax obligations on the settlement of the previously reported vesting of the Reporting Person's restricted share units. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:26 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantCommon Shares | 52.874 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002455 · doc4.xml · nonDerivative · entry 1 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,639.0369 F1 · shares: Represents shares settled from dividend equivalent rights that accrued on a vested restricted share unit award in respect of dividends that were paid after the vesting of the award with a record date prior to the vesting of the award. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:27 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantPerformance Share Units · Derivative | 6,279.0698 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002456 · doc4.xml · derivative · entry 4 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756,279.0698 Underlying: Common Shares · 6,279.0698 shares Expires not disclosed F5 · derivative.exercise_price: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending March 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. F5 · derivative.exercise_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending March 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F5 · derivative.expiration_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending March 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:27 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantRestricted Share Units · Derivative | 4,186.0465 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002456 · doc4.xml · derivative · entry 3 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504,186.0465 Underlying: Common Shares · 4,186.0465 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal installments on November 21, 2023, November 21, 2024, November 21, 2025, November 21, 2026 and November 21, 2027. F4 · derivative.expiration_date: These restricted share units vest in equal installments on November 21, 2023, November 21, 2024, November 21, 2025, November 21, 2026 and November 21, 2027. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:33 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 297.8717 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002465 · doc4.xml · derivative · entry 19 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,876.9969 Underlying: Common Shares · 297.8717 shares Expires 2025-02-25 F16 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:33 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 110.4959 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002465 · doc4.xml · derivative · entry 18 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,308.6215 Underlying: Common Shares · 110.4959 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F15 · derivative.exercise_date: The restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F15 · derivative.expiration_date: The restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:33 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 179.2185 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002465 · doc4.xml · derivative · entry 17 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,585.8669 Underlying: Common Shares · 179.2185 shares Expires 2024-02-19 F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:33 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 46.7662 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002465 · doc4.xml · derivative · entry 16 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,632.73 Underlying: Common Shares · 46.7662 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.